What is the TRYP.CN share price today?

This page shows the latest available Tryp Therapeutics Inc. (TRYP.CN) price with its change against the prior close. Values are delayed or previous-close, not real-time.

Where is Tryp Therapeutics Inc. listed?

Tryp Therapeutics Inc. trades on the Canadian Securities Exchange under the symbol TRYP.CN, ISIN CA89854F1062.

How large is Tryp Therapeutics Inc.?

Its market capitalisation is approximately 5.79M CAD, based on the latest available price and share count from our data provider.

Canadian Securities Exchange (CSE) · TRYP.CN · ISIN CA89854F1062

Tryp Therapeutics Inc.

No trading activity has been reported for this listing since April 29, 2024. It may be delisted, halted or inactive.

0.0600 CAD

April 29, 2024

Tryp Therapeutics Inc. (TRYP.CN) trades on the Canadian Securities Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 5.79M CAD. Its ISIN is CA89854F1062. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Key facts

Exchange

Canadian Securities Exchange (CSE)

ISIN

CA89854F1062

Sector

Healthcare

Industry

Biotechnology

Country

Market cap

5.79M CAD

Previous close

0.06 CAD

Day range

0.06 – 0.06

52-week range

0.01 – 0.11

Volume

Asset type

Equity

About Tryp Therapeutics Inc.

Tryp Therapeutics Inc. is a pharmaceutical firm dedicated to discovering and advancing innovative compounds for medical conditions lacking adequate treatment options. Its primary research and development initiative, known as PFN, centers on utilizing synthetic psilocybin formulations to address a range of neuropsychiatric disorders. Key candidates within the PFN pipeline, TRP-8802 and TRP-8803, are being explored for potential applications in challenging conditions such as fibromyalgia, phantom limb pain, binge eating disorder, complex regional pain syndrome, and hypothalamic obesity. To support its endeavors, Tryp Therapeutics has forged alliances, including an agreement with Calvert Labs for designing and conducting exploratory studies pertinent to its psilocybin-based neuropsychiatric program. Additionally, a service agreement with Fluence ensures specialized design and training for the psychotherapeutic components crucial to Tryp's clinical trial activities. Initially established as Artos Pharma Corp. in 2019, the company adopted its current name, Tryp Therapeutics Inc., in June 2020. It operates from its base in Kelowna, Canada.

Company website

Frequently asked

What is the TRYP.CN share price today?: This page shows the latest available Tryp Therapeutics Inc. (TRYP.CN) price with its change against the prior close. Values are delayed or previous-close, not real-time.
Where is Tryp Therapeutics Inc. listed?: Tryp Therapeutics Inc. trades on the Canadian Securities Exchange under the symbol TRYP.CN, ISIN CA89854F1062.
How large is Tryp Therapeutics Inc.?: Its market capitalisation is approximately 5.79M CAD, based on the latest available price and share count from our data provider.

All Tryp Therapeutics Inc. data comes from exchange and provider feeds for the Canadian Securities Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.